We hereby inform that the Board of Directors of the Company at its meeting held today i.e. on Friday, May 29, 2026, inter alia, considered and approved the following matters: 1. Audited ....
MKPL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
M. K. Proteins Limited reported audited standalone financial results for FY ended March 31, 2026. Total revenue from operations grew by 43% to Rs 38,287.52 Lakhs from Rs 26,770.60 Lakhs in the previous year, driven by higher volumes in vegetable refined oil manufacturing. However, profit after tax (PAT) declined by 18.7% to Rs 682.90 Lakhs from Rs 839.74 Lakhs, indicating margin compression despite revenue growth. Finance costs rose significantly to Rs 185.20 Lakhs (vs Rs 110.50 Lakhs). EBITDA for the year was approximately Rs 1,167.69 Lakhs, translating to a margin of ~3.05% vs ~4.28% prior year. The auditors issued an unmodified opinion. The company reduced outstanding qualified borrowings from Rs 37.75 Crores to Rs 36.19 Crores during the year. Related party transactions for the half-year were also disclosed.
Revenue growth of 43% is positive but the 18.7% PAT decline signals cost pressures and margin erosion, which could weigh on investor sentiment despite a clean audit. The company's high debt level (Rs 36.19 Crores) relative to equity (Rs 7,630.02 Lakhs) also warrants monitoring.